Triumeq and Social Security Disability Benefits
TELL US WHAT HAPPENED SO WE CAN HELP. FREE CONSULTATION
Contact Us About Your Case
FREE Consultation Today.
Triumeq and Social Security Disability Benefits
Triumeq is a prescription medication used to treat HIV-1 infection. It combines three antiretroviral medicines in one regimen:
- abacavir
- dolutegravir
- lamivudine
Triumeq can be used as a complete HIV treatment regimen in eligible patients. Current FDA prescribing information also requires screening for the HLA-B*5701 allele before treatment because abacavir can cause potentially life-threatening hypersensitivity reactions.
Taking Triumeq does not automatically qualify someone for Social Security Disability benefits.
Many people taking Triumeq achieve durable viral suppression and remain capable of working. Others continue to experience HIV-related complications, severe fatigue, neuropathy, cognitive problems, recurrent illness, or treatment effects that interfere with sustained employment.
The important question is not simply whether someone takes Triumeq.
It is whether HIV, its complications, and the effects of treatment prevent the person from sustaining full-time competitive work.
What Is Triumeq?
Triumeq combines three HIV medications:
- dolutegravir, an integrase strand transfer inhibitor
- abacavir, a nucleoside reverse transcriptase inhibitor
- lamivudine, another nucleoside reverse transcriptase inhibitor
FDA prescribing information identifies Triumeq and Triumeq PD as complete HIV-1 treatment regimens for eligible adults and pediatric patients.
Modern antiretroviral treatment can dramatically reduce HIV-related illness and preserve immune function. Current NIH HIV guidelines emphasize sustained viral suppression as a central goal of treatment.
But successful antiviral treatment does not necessarily eliminate every functional problem associated with HIV.
A person may continue to experience:
- severe fatigue
- neuropathy
- cognitive impairment
- chronic pain
- depression
- liver disease
- complications from prior infections
- treatment side effects
Can Taking Triumeq Qualify You for Social Security Disability?
Not by itself.
A Triumeq prescription helps document treatment for HIV, but Social Security evaluates the underlying disease and its functional effects.
A stronger disability claim may exist when medically documented problems cause:
- reduced stamina
- frequent illness
- difficulty walking
- hand limitations from neuropathy
- cognitive impairment
- headaches
- insomnia
- medication-related fatigue
- frequent treatment
- excessive absences
- inability to complete full shifts
The strongest claims connect the medical evidence to specific workplace limitations.
Triumeq and HIV Disability Claims
Adult HIV infection is evaluated under Social Security Blue Book Listing 14.11.
Depending on the medical evidence, a person may qualify through:
- certain serious HIV-related diseases
- very low CD4 counts
- qualifying low CD4 measurements combined with severe weight loss or anemia
- repeated HIV-related hospitalizations
- repeated manifestations of HIV causing marked functional limitations
A person who does not meet Listing 14.11 may still qualify if their Residual Functional Capacity, or RFC, prevents them from performing past work or other competitive employment.
Triumeq and Viral Suppression
Triumeq may successfully suppress HIV to undetectable levels.
That is an important medical success, but an undetectable viral load does not automatically establish the ability to work.
A person may remain limited by:
- peripheral neuropathy
- severe fatigue
- cognitive impairment
- chronic gastrointestinal problems
- depression or anxiety
- liver disease
- residual effects of earlier opportunistic infections
- other medical conditions
Social Security should evaluate how the person actually functions despite effective antiviral treatment.
Triumeq and Fatigue
Fatigue is one of the most commonly reported adverse reactions of at least moderate intensity in clinical trials of Triumeq. Current prescribing information lists insomnia, headache, and fatigue among its most common adverse reactions.
Fatigue may also come from HIV itself or related conditions such as:
- anemia
- chronic infection
- depression
- poor sleep
- chronic pain
- nutritional problems
Work-related limitations may include:
- reduced stamina
- slower pace
- poor concentration
- need for extra breaks
- difficulty working consecutive days
- inability to complete full shifts
Triumeq and Insomnia
Insomnia is another common Triumeq adverse reaction.
Poor sleep may contribute to:
- daytime fatigue
- poor concentration
- slower thinking
- irritability
- reduced productivity
- difficulty maintaining reliable attendance
For someone already dealing with HIV-related fatigue or cognitive problems, persistent insomnia may further reduce the ability to sustain a normal work schedule.
Triumeq and Headaches
Headache is also among Triumeq’s most commonly reported adverse reactions.
Frequent or severe headaches may interfere with:
- concentration
- computer work
- reading
- pace
- attendance
- ability to complete tasks
The existence of occasional headaches usually will not establish disability.
What matters is whether headaches are severe, frequent, medically documented, and functionally limiting.
Triumeq and Abacavir Hypersensitivity
One of the most important safety issues with Triumeq involves abacavir hypersensitivity.
Triumeq carries a boxed warning for potentially serious and sometimes fatal hypersensitivity reactions associated with abacavir.
Before treatment, patients should be screened for the HLA-B*5701 allele. Triumeq is contraindicated in people who test positive for HLA-B*5701 or who have previously experienced an abacavir hypersensitivity reaction.
Symptoms of a hypersensitivity reaction may involve combinations of:
- fever
- rash
- fatigue
- gastrointestinal symptoms
- respiratory symptoms
If an abacavir hypersensitivity reaction is suspected, treatment requires immediate medical attention and the medication should not simply be restarted later without appropriate medical guidance.
For disability purposes, a hypersensitivity reaction may become relevant if it results in:
- emergency treatment
- hospitalization
- prolonged recovery
- medication changes
- significant time away from work
Triumeq and Hepatitis B
Triumeq also carries a boxed warning relating to hepatitis B.
Lamivudine has activity against hepatitis B, but HIV/HBV coinfection requires careful treatment planning because hepatitis B may become resistant to lamivudine when it is used without another effective HBV medication.
Severe acute exacerbations of hepatitis B have also been reported after discontinuation of lamivudine-containing treatment.
Patients should therefore be tested for hepatitis B before or when starting Triumeq, and people with HIV/HBV coinfection may require additional treatment and monitoring.
Hepatitis B complications may contribute to:
- fatigue
- weakness
- nausea
- liver dysfunction
- reduced stamina
- additional medical appointments
Triumeq and Liver Problems
Current prescribing information warns that hepatotoxicity has occurred with dolutegravir-containing regimens.
People with underlying hepatitis B or hepatitis C may have an increased risk of liver-related complications.
Liver problems may cause:
- severe fatigue
- weakness
- nausea
- reduced stamina
- additional testing
- medication changes
- hospitalization in serious cases
For Social Security purposes, the important question is whether actual liver disease produces documented functional limitations.
Triumeq and Cardiovascular Risk
Current Triumeq labeling also addresses the possible association between abacavir and myocardial infarction.
Studies evaluating this issue have not all reached the same conclusion, but current labeling advises clinicians to consider underlying coronary heart disease risk when prescribing abacavir-containing treatment.
This may be particularly relevant for a person who also has:
- coronary artery disease
- hypertension
- diabetes
- smoking history
- elevated cardiovascular risk
A medication warning does not itself establish disability.
If cardiovascular disease actually develops, however, resulting limitations involving stamina, exertion, chest symptoms, or attendance should be considered separately.
Triumeq and Kidney Function
Kidney function can also affect whether the fixed-dose Triumeq tablet is appropriate.
Because lamivudine ordinarily requires dosage adjustment at reduced kidney function, Triumeq may not be recommended in some patients with significant renal impairment because the individual components cannot be separately adjusted within the fixed-dose tablet.
Kidney disease itself may contribute to:
- fatigue
- weakness
- swelling
- reduced endurance
- difficulty concentrating
- additional medical treatment
Those limitations should be considered as part of the overall disability analysis when medically documented.
Triumeq and Drug Interactions
Triumeq can interact with other medications.
Current prescribing information specifically contraindicates its use with dofetilide and identifies other medications that may alter dolutegravir concentrations or otherwise affect treatment.
Drug interactions may become relevant when they cause:
- treatment changes
- increased side effects
- additional monitoring
- difficulty maintaining a stable regimen
- reduced treatment options
A disability evaluation should consider the person’s entire treatment regimen rather than one medication in isolation.
Triumeq and Peripheral Neuropathy
Peripheral neuropathy may occur in people living with HIV even when antiviral therapy is effective.
Symptoms may include:
- burning pain
- tingling
- numbness
- weakness
- reduced sensation
- balance problems
Neuropathy affecting the feet may interfere with:
- standing
- walking
- climbing
- balance
- driving
Neuropathy affecting the hands may interfere with:
- typing
- writing
- gripping
- handling
- fingering
Triumeq and Cognitive Problems
Some people living with HIV experience neurocognitive symptoms even with successful treatment.
Possible symptoms include:
- memory problems
- poor concentration
- slowed thinking
- difficulty organizing tasks
- reduced mental stamina
- difficulty learning new information
At work, these problems may lead to:
- mistakes
- forgotten instructions
- missed deadlines
- reduced pace
- excessive off-task time
- difficulty multitasking
Triumeq and Mental Health Symptoms
A disability claim involving HIV may also include:
- depression
- anxiety
- social withdrawal
- sleep disturbance
- difficulty handling stress
Mental health symptoms may affect:
- concentration
- motivation
- pace
- workplace relationships
- attendance
- ability to complete tasks
Social Security should consider medically documented mental and physical limitations together.
Can You Work While Taking Triumeq?
Yes.
Many people taking Triumeq work successfully.
The medication itself is not evidence that someone is unable to work.
The more important questions are:
- Is HIV adequately controlled?
- What complications remain?
- Are medication side effects significant?
- Is fatigue severe?
- Are cognitive problems present?
- How often does the person miss work?
- Can the person complete a normal workday and workweek?
Two people taking the same medication may have very different functional abilities.
Can Triumeq-Related Conditions Prevent Sedentary Work?
Yes.
Sedentary work still requires:
- regular attendance
- sustained concentration
- consistent pace
- hand use
- some standing and walking
- reliable completion of full workdays
Sedentary work may become difficult when:
- fatigue reduces stamina
- insomnia causes daytime impairment
- headaches interfere with concentration
- neuropathy limits hand use or mobility
- cognitive problems cause excessive off-task time
- liver or kidney disease reduces endurance
- recurrent illness causes excessive absences
Simply being physically capable of sitting at a desk does not establish the ability to sustain full-time employment.
Triumeq and Residual Functional Capacity
Residual Functional Capacity, or RFC, describes the most a person can still do despite medical limitations.
An HIV claim involving Triumeq may include restrictions related to:
- standing
- walking
- lifting
- carrying
- handling
- fingering
- concentration
- pace
- workplace hazards
- additional breaks
- off-task time
- attendance
For example:
- Fatigue may reduce stamina and productivity.
- Neuropathy may limit walking or hand use.
- Cognitive impairment may limit complex tasks.
- Insomnia may reduce daytime concentration.
- Headaches may cause off-task time.
- Recurrent illness may result in excessive absences.
The RFC should reflect the combined effects of HIV, coexisting conditions, and treatment.
Medical Evidence That May Support a Triumeq And Social Security Disability Claim
Helpful medical evidence may include:
- infectious disease specialist records
- primary care records
- CD4 counts
- viral-load testing
- HLA-B*5701 testing
- hepatitis testing
- liver-function testing
- kidney-function testing
- hospitalization records
- infection records
- neuropathy evaluations
- cognitive testing
- psychiatric records
- medication history
- documented side effects
- records of missed work
- provider statements describing specific work limitations
The strongest evidence connects the medical findings to actual workplace problems.
Documenting Triumeq Side Effects
Medication side effects are more persuasive when they are consistently documented.
Helpful evidence may include:
- fatigue
- insomnia
- headaches
- gastrointestinal symptoms
- hypersensitivity reactions
- liver abnormalities
- medication changes
- drug-interaction concerns
- treatment interruptions
The disability claim should explain not simply that a symptom exists, but how often it occurs and how it affects the ability to work.
Doctor Statements About Work Limitations
A treating provider may be able to address:
- fatigue
- walking tolerance
- neuropathy
- hand use
- cognitive impairment
- concentration
- headaches
- treatment side effects
- need for additional breaks
- expected absences
- ability to maintain pace
- ability to complete a full workday
Specific functional opinions are generally more useful than a broad statement that someone is “disabled.”
Signs Triumeq May Be Relevant to Your Disability Claim
Triumeq treatment may be relevant when HIV or related medical problems continue to cause:
- severe fatigue
- recurrent infections
- neuropathy
- cognitive impairment
- persistent headaches
- severe sleep disturbance
- liver complications
- kidney disease
- significant treatment effects
- excessive absences
- inability to complete full shifts
When these limitations remain persistent and medically documented, the disability claim may be stronger.
Common Mistakes in Triumeq Disability Claims
Common problems include:
- relying on the medication itself as proof of disability
- assuming an HIV diagnosis automatically establishes disability
- assuming an undetectable viral load automatically proves ability to work
- failing to document fatigue
- ignoring neuropathy
- overlooking cognitive problems
- failing to document treatment effects
- overlooking liver or kidney problems
- failing to explain excessive absences
- failing to connect symptoms to specific RFC limitations
A strong claim focuses on what the person can and cannot reliably do despite effective HIV treatment.
When to Speak With a Social Security Disability Lawyer
Many people seek legal help when:
- their disability claim has been denied
- HIV complications continue despite Triumeq
- fatigue prevents full-time work
- neuropathy affects mobility or hand use
- cognitive problems interfere with employment
- liver or kidney disease creates additional limitations
- treatment complications cause missed work
- recurrent illness results in excessive absences
- Social Security assumes viral suppression means the person can work
Our social security disability attorneys can help evaluate how HIV, Triumeq treatment, medical complications, medication effects, and RFC limitations fit into the overall disability claim.
FAQs: Triumeq and Social Security Disability Benefits
Can taking Triumeq qualify me for Social Security Disability?
Not by itself. Social Security evaluates HIV, related medical complications, treatment effects, and the ability to sustain full-time work.
What is Triumeq used to treat?
Triumeq is an FDA-approved complete regimen for treatment of HIV-1 in eligible patients. It combines abacavir, dolutegravir, and lamivudine.
What medications are in Triumeq?
Triumeq contains 600 mg of abacavir, 50 mg of dolutegravir, and 300 mg of lamivudine in the adult fixed-dose tablet.
Why is HLA-B*5701 testing important before Triumeq?
Abacavir can cause potentially life-threatening hypersensitivity reactions. Current prescribing information requires screening for the HLA-B*5701 allele before beginning Triumeq. People who test positive should not take the medication.
What are common Triumeq side effects?
Current prescribing information identifies insomnia, headache, and fatigue as the most commonly reported adverse reactions of at least moderate intensity occurring in at least 2% of patients in the relevant clinical trial data.
Can Triumeq cause liver problems?
Yes. Hepatotoxicity has been reported with dolutegravir-containing regimens, and liver monitoring may be appropriate, particularly in people with underlying liver disease.
Why is hepatitis B important when taking Triumeq?
Triumeq contains lamivudine. Current labeling warns about development of lamivudine-resistant hepatitis B and severe hepatitis B exacerbations after stopping lamivudine-containing treatment. HIV/HBV coinfection requires appropriate medical management.
Does Triumeq have cardiovascular concerns?
Current labeling discusses a possible association between abacavir and myocardial infarction. The evidence has been mixed, but cardiovascular risk should be considered when choosing an abacavir-containing regimen.
Is Triumeq still a preferred first-line HIV medication?
Treatment recommendations have evolved. Current 2026 NIH guidelines recommend several modern integrase-based regimens for most people starting HIV therapy, including bictegravir-based treatment and dolutegravir/lamivudine in appropriate patients. Abacavir-containing treatment may still be used in selected situations, but regimen choice depends on resistance, hepatitis B status, cardiovascular risk, kidney function, and other individual factors.
Can I qualify for disability if Triumeq keeps my viral load undetectable?
Potentially. Viral suppression is medically important, but it does not automatically determine work capacity. Persistent fatigue, neuropathy, cognitive impairment, liver or kidney disease, recurrent illness, treatment effects, or other limitations may still prevent sustained employment.
Can HIV prevent sedentary work?
Yes. Severe fatigue, cognitive impairment, neuropathy, headaches, sleep problems, recurrent illness, or excessive absences may make even sedentary work unsustainable.
What evidence helps prove a Triumeq-related disability claim?
Helpful evidence may include infectious disease records, CD4 and viral-load testing, HLA-B*5701 testing, hepatitis testing, liver and kidney studies, neuropathy evaluations, cognitive or psychiatric records, medication history, documented treatment effects, and provider statements describing specific work limitations.
What should I do if HIV prevents me from working despite Triumeq?
You may want to speak with a Social Security Disability attorney to evaluate whether your HIV meets Listing 14.11 or whether your combined symptoms, complications, treatment effects, and RFC limitations prevent sustained employment.
Contact MLF Legal for a Free Disability Case Evaluation
If HIV, severe fatigue, neuropathy, cognitive impairment, recurrent infections, Triumeq side effects, or another medical condition prevents you from working, you may qualify for Social Security Disability benefits.
MLF Legal represents disability applicants nationwide. Based in Dallas, Texas, we help individuals across the country pursue disability benefits.
Our social security lawyers can review your situation for free and explain your options.
📞 Call MLF Legal at 214-357-1782 to request a free consultation.
Next Steps:
1st Sign up For a Free One-on-One Disability Case Evaluation
Contact us today to schedule your personalized one-on-one free phone consultation with one of our dedicated legal professionals. Our experienced social security lawyers are here to provide the expert legal guidance and support you need throughout the entire process of your case.
We understand the complexities involved in social security disability claims and are committed to helping you achieve the best possible outcome. Don’t hesitate to reach out and take the first step toward securing the justice you deserve.
2nd Download Free E-Books
Social Security Disability
Navigating the Social Security Disability Benefits process can be complex, but understanding the key steps can help. From gathering medical records to completing the application, this process ensures eligible individuals receive the support they need. Seeking guidance from experts can simplify the journey and increase the chances of a successful outcome.
Call MLF Legal today
214-357-1782
Fill out our online form
for a free consultation.
We only get paid if we win your case.